Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition

Susan Wyllie
, Stephen Brand
, Michael Thomas
, Manu De Rycker
, Chun-Wa Chung
, Imanol Peña
, Ryan Bingham
, Juan Bueren-Calabuig
, Juan Cantizani
, David Cebrian
, Peter D. Craggs
, Liam Ferguson
, Panchali Goswami
, Judith Hobrath
, Jonathan Howe
, Laura Jeacock
, Eun Jung Ko
, Justyna Korczynska
, Lorna MacLean
, Sujatha Manthri

Maria Santos Martinez, Lydia Mata-Cantero, Sonia Moniz, Andrea Nuhs, Maria Osuna-Cabello, Erika Pinto, Jennifer Riley, Sharon Robinson, Paul Rowland, Frederick Simeons, Yoko Shishikura, Daniel Spinks, Laste Stojanovski, John Thomas, Stephen Thompson, Elisabet Viayna Gaza, Richard Wall, Fabio Zuccotto, David Horn, Michael Ferguson, Alan Fairlamb, Jose M. Fiandor, Julio Martín, David Gray, Timothy J. Miles, Ian Gilbert, Kevin Read (Lead / Corresponding author), Maria Marco (Lead / Corresponding author), Paul Wyatt (Lead / Corresponding author)

Research output: Contribution to journal › Article › peer-review

140 Citations (Scopus)

330 Downloads (Pure)

1 results
- Last Name(descending)

Read, Kevin
- Drug Discovery Unit - Professor of Quantitative Pharmacology
Person: Academic